Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1997 May;50(5):401–406. doi: 10.1136/jcp.50.5.401

In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features.

V Paradis 1, P Mathurin 1, M Kollinger 1, F Imbert-Bismut 1, F Charlotte 1, A Piton 1, P Opolon 1, A Holstege 1, T Poynard 1, P Bedossa 1
PMCID: PMC499942  PMID: 9215123

Abstract

AIMS: To assess the occurrence of lipid peroxidation in chronic hepatitis C and to evaluate its relation to pathological features and liver iron concentrations. METHODS: Liver biopsy samples of 43 patients with untreated chronic hepatitis C were studied by immunohistochemistry using specific antibodies directed against two major aldehyde metabolites of lipid peroxidation, malondialdehyde (MDA), and 4-hydroxynonenal (HNE). RESULTS: MDA and HNE adducts (aldehydes covalently linked to another molecule) were detected in the liver samples in 77% and 30% of cases, respectively. MDA adducts were detected both in the extracellular matrix and sinusoidal cells localised in areas of periportal and lobular necrosis. HNE adducts appeared in the cytoplasm of only a few hepatocytes. Comparison of the semiquantitative assessment of adducts (MDA and HNE indexes) with the grading and the staging of chronic hepatitis showed that the MDA index was correlated with fibrosis score (p < 0.001) and the grade of activity (p < 0.01). There was also a tendency to correlation with liver iron concentration (p = 0.09). No correlation was observed between the HNE index and pathological features or liver iron concentration. CONCLUSION: Lipid peroxidation products are detectable in the liver of chronic hepatitis C patients. The presence of MDA adducts in areas of active fibrogenesis and the correlation between the MDA index and fibrosis score suggest a role for lipid peroxidation in liver fibrosis.

Full text

PDF
401

Images in this article

404Image
on p.404

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bachem M. G., Meyer D., Melchior R., Sell K. M., Gressner A. M. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest. 1992 Jan;89(1):19–27. doi: 10.1172/JCI115561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bedossa P., Houglum K., Trautwein C., Holstege A., Chojkier M. Stimulation of collagen alpha 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology. 1994 May;19(5):1262–1271. [PubMed] [Google Scholar]
  3. Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996 Aug;24(2):289–293. doi: 10.1002/hep.510240201. [DOI] [PubMed] [Google Scholar]
  4. Britton R. S., Bacon B. R. Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology. 1994 Aug;41(4):343–348. [PubMed] [Google Scholar]
  5. Cheeseman K. H. Mechanisms and effects of lipid peroxidation. Mol Aspects Med. 1993;14(3):191–197. doi: 10.1016/0098-2997(93)90005-x. [DOI] [PubMed] [Google Scholar]
  6. Chojkier M., Houglum K., Solis-Herruzo J., Brenner D. A. Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. A role for lipid peroxidation? J Biol Chem. 1989 Oct 5;264(28):16957–16962. [PubMed] [Google Scholar]
  7. Cooksley W. G., Bradbear R. A., Robinson W., Harrison M., Halliday J. W., Powell L. W., Ng H. S., Seah C. S., Okuda K., Scheuer P. J. The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology. 1986 May-Jun;6(3):345–348. doi: 10.1002/hep.1840060302. [DOI] [PubMed] [Google Scholar]
  8. Esterbauer H., Schaur R. J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11(1):81–128. doi: 10.1016/0891-5849(91)90192-6. [DOI] [PubMed] [Google Scholar]
  9. Farinati F., Cardin R., D'Errico A., De Maria N., Naccarato R., Cecchetto A., Grigioni W. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology. 1996 Jun;23(6):1468–1475. doi: 10.1053/jhep.1996.v23.pm0008675166. [DOI] [PubMed] [Google Scholar]
  10. Farinati F., Cardin R., De Maria N., Della Libera G., Marafin C., Lecis E., Burra P., Floreani A., Cecchetto A., Naccarato R. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol. 1995 Apr;22(4):449–456. doi: 10.1016/0168-8278(95)80108-1. [DOI] [PubMed] [Google Scholar]
  11. Farinati F., Cardin R., de Maria N., Lecis P. E., Della Libera G., Burra P., Marafin C., Sturniolo G. C., Naccarato R. Zinc, iron, and peroxidation in liver tissue. Cumulative effects of alcohol consumption and virus-mediated damage--a preliminary report. Biol Trace Elem Res. 1995 Jan-Mar;47(1-3):193–199. doi: 10.1007/BF02790117. [DOI] [PubMed] [Google Scholar]
  12. Genetic diversity of hepatitis C virus: implications for pathogenesis, treatment, and prevention. Report of a meeting of Physicians and Scientists. Lancet. 1995 Mar 4;345(8949):562–566. [PubMed] [Google Scholar]
  13. Habeeb A. F. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem. 1966 Mar;14(3):328–336. doi: 10.1016/0003-2697(66)90275-2. [DOI] [PubMed] [Google Scholar]
  14. Higueras V., Raya A., Rodrigo J. M., Serra M. A., Romá J., Romero F. J. Interferon decreases serum lipid peroxidation products of hepatitis C patients. Free Radic Biol Med. 1994 Jan;16(1):131–133. doi: 10.1016/0891-5849(94)90250-x. [DOI] [PubMed] [Google Scholar]
  15. Janero D. R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med. 1990;9(6):515–540. doi: 10.1016/0891-5849(90)90131-2. [DOI] [PubMed] [Google Scholar]
  16. Kamimura S., Gaal K., Britton R. S., Bacon B. R., Triadafilopoulos G., Tsukamoto H. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. Hepatology. 1992 Aug;16(2):448–453. doi: 10.1002/hep.1840160225. [DOI] [PubMed] [Google Scholar]
  17. Liaw Y. F., Tai D. I., Chu C. M., Chen T. J. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology. 1988 May-Jun;8(3):493–496. doi: 10.1002/hep.1840080310. [DOI] [PubMed] [Google Scholar]
  18. Olynyk J. K., O'Neill R., Britton R. S., Bacon B. R. Determination of hepatic iron concentration in fresh and paraffin-embedded tissue: diagnostic implications. Gastroenterology. 1994 Mar;106(3):674–677. doi: 10.1016/0016-5085(94)90701-3. [DOI] [PubMed] [Google Scholar]
  19. Palinski W., Ylä-Herttuala S., Rosenfeld M. E., Butler S. W., Socher S. A., Parthasarathy S., Curtiss L. K., Witztum J. L. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 1990 May-Jun;10(3):325–335. doi: 10.1161/01.atv.10.3.325. [DOI] [PubMed] [Google Scholar]
  20. Parola M., Pinzani M., Casini A., Albano E., Poli G., Gentilini A., Gentilini P., Dianzani M. U. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells. Biochem Biophys Res Commun. 1993 Aug 16;194(3):1044–1050. doi: 10.1006/bbrc.1993.1927. [DOI] [PubMed] [Google Scholar]
  21. Poli G. Liver damage due to free radicals. Br Med Bull. 1993 Jul;49(3):604–620. doi: 10.1093/oxfordjournals.bmb.a072634. [DOI] [PubMed] [Google Scholar]
  22. Poli G., Parola M., Leonarduzzi G., Pinzani M. Modulation of hepatic fibrogenesis by antioxidants. Mol Aspects Med. 1993;14(3):259–264. doi: 10.1016/0098-2997(93)90013-4. [DOI] [PubMed] [Google Scholar]
  23. Recknagel R. O., Glende E. A., Jr, Dolak J. A., Waller R. L. Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther. 1989;43(1):139–154. doi: 10.1016/0163-7258(89)90050-8. [DOI] [PubMed] [Google Scholar]
  24. Uchida K., Szweda L. I., Chae H. Z., Stadtman E. R. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8742–8746. doi: 10.1073/pnas.90.18.8742. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES